| 1 |
Zhou LF, Zhang MS, Hu AH, et al. Selective blockade of NF-κB by novel mutated IκBα suppresses CD3/CD28-induced activation of memory CD4+ T cells in asthma[J]. Allergy, 2008, 63(5): 509-517.
|
| 2 |
Chen JQ, Szodoray P, Zeher M. Toll-Like receptor pathways in autoimmune diseases[J]. Clin Rev Allergy Immunol, 2016, 50(1): 1-17.
|
| 3 |
Crespo-Lessmann A, Mateus E, Vidal S, et al. Expression of toll-like receptors 2 and 4 in subjects with asthma by total serum IgE level[J]. Respir Res, 2016, 17: 41.
|
| 4 |
He M, Ichinose T, Song Y, et al. Desert dust induces TLR signaling to trigger Th2-dominant lung allergic inflammation via a MyD88-dependent signaling pathway[J]. Toxicol Appl Pharmacol, 2016, 296: 61-72.
|
| 5 |
Lee HY, Rhee CK, Kang JY, et al. Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma[J]. Korean J Intern Med, 2016, 31(1): 89-97.
|
| 6 |
Hosoki K, Itazawa T, Boldogh I, et al. Neutrophil recruitment by allergens contribute to allergic sensitization and allergic inflammation[J]. Curr Opin Allergy Clin Immunol, 2016, 16(1): 45-50.
|
| 7 |
Medzhitov R, Preston-Hurlburt P, Janeway CA, et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997, 388(6640): 394-397.
|
| 8 |
Shi Z, Cai Z, Sanchez A, et al. A novel Toll-like receptor that recognizes vesicular stomatitis virus[J]. J Biol Chem, 2011, 286(6): 4517-4524.
|
| 9 |
Aryan Z, Rezaei N. Toll-like receptors as targets for allergen immunotherapy [J]. Curr Opin Allergy Clin Immunol, 2015, 15(6): 568-574.
|
| 10 |
Park BS, Song DH, Kim HM, et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex[J]. Nature, 2009, 458(7242): 1191-1195.
|
| 11 |
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors [J]. Nat Immunol, 2010, 11(5): 373-384.
|
| 12 |
Kuramochi M, Izawa T, Pervin M, et al. The kinetics of damage-associated molecular patterns (DAMPs) and toll-like receptors during thioacetamide-induced acute liver injury in rats[J]. Exp Toxicol Pathol, 2016, 68(8): 471-477.
|
| 13 |
Pham DL, Yoon MG, Ban GY, et al. Serum S100A8 and S100A9 enhance innate immune responses in the pathogenesis of baker′s asthma[J]. Int Arch Allergy Immunol, 2015, 168(2): 138-146.
|
| 14 |
Di Candia L, Gomez E, Venereau E, et al. HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4[J]. J Allergy Clin Immunol, 2017, 140(2): 584-587.e588.
|
| 15 |
Ojo OO, Ryu MH, Jha A, et al. High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells[J]. Am J Physiol Lung Cell Mol Physiol, 2015, 309(11): L1354-1366.
|
| 16 |
Zhang H, Yang N, Wang T, et al. Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NFkappaB signaling pathway[J]. Mol Med Rep, 2018, 17(2): 2915-2920.
|
| 17 |
Strachan DP. Hay fever, hygiene, and household size[J]. BMJ (Clinical research ed), 1989, 299(6710): 1259-1260.
|
| 18 |
Haapakoski R, Karisola P, Fyhrquist N, et al. Toll-like receptor activation during cutaneous allergen sensitization blocks development of asthma through IFN-γ -dependent mechanisms[J]. J Invest Dermatol, 2013, 133(4): 964-972.
|
| 19 |
Prefontaine D, Banville-Langelier AA, Fiset PO, et al. Children with atopic histories exhibit impaired lipopolysaccharide-induced Toll-like receptor-4 signalling in peripheral monocytes[J]. Clin Exp Allergy, 2010, 40(11): 1648-1657.
|
| 20 |
Bantz SK, Zhu Z, Zheng T. The Atopic March: progression from atopic dermatitis to allergic rhinitis and asthma[J]. J Clin Cell Immunol, 2014, 5(2): 202.
|
| 21 |
Chen L, Guo S, Ranzer MJ, et al. Toll-like receptor 4 has an essential role in early skin wound healing[J]. J Invest Dermatol, 2013, 133(1): 258-267.
|
| 22 |
Dickinson SE, Wondrak GT. TLR4-directed molecular strategies targeting skin photodamage and carcinogenesis[J]. Curr Med Chem, 2018, 25(40): 5487-5502.
|
| 23 |
Kemeny L, Szabo K. Toll-like receptors link atopic march to the hygiene hypothesis[J]. J Invest Dermatol, 2013, 133(4): 874-878.
|
| 24 |
Ryu JH, Yoo JY, Kim MJ, et al. Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airways[J]. J Allergy Clin Immunol, 2013, 131(2): 549-561.
|
| 25 |
McAlees JW, Whitehead GS, Harley IT, et al. Distinct Tlr4-expressing cell compartments control neutrophilic and eosinophilic airway inflammation[J]. Mucosal Immunol, 2015, 8(4): 863-873.
|
| 26 |
Mac Sharry J, Shalaby KH, Marchica C, et al. Concomitant exposure to ovalbumin and endotoxin augments airway inflammation but not airway hyperresponsiveness in a murine model of asthma[J]. PLoS One, 2014, 9(6): e98648-98659.
|
| 27 |
Nishihara F, Nakagome K, Kobayashi T, et al. Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitro[J]. ERJ Open Res, 2015, 1(2). pii: 00003-2015.
|
| 28 |
Wang WL, Li HY, Zhang MS, et al. Thymic stromal lymphopoietin: a promising therapeutic target for allergic diseases[J]. Int Arch Allergy Immunol, 2013，160(1): 18-26.
|
| 29 |
Tjota MY, Hrusch CL, Blaine KM, et al. Signaling through FcRγ-associated receptors on dendritic cells drives IL-33-dependent TH2-type responses[J]. J Allergy Clin Immunol, 2014, 134(3): 706-713.
|
| 30 |
Nembrini C, Sichelstiel A, Kisielow J, et al. Bacterial-induced protection against allergic inflammation through a multicomponent immunoregulatory mechanism[J]. Thorax, 2011, 66(9): 755-763.
|
| 31 |
Thorburn AN, Tseng HY, Donovan C, et al. TLR2, TLR4 and MyD88 mediate allergic airway disease (AAD) and streptococcus pneumoniae-induced suppression of AAD[J]. PLoS One, 2016, 11(6): e0156402.
|
| 32 |
Starkhammar M, Larsson O, Kumlien Georen S, et al. Toll-like receptor ligands LPS and poly (I︰C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation[J]. PLoS One, 2014, 9(8): e104114.
|
| 33 |
Ullah MA, Loh Z, Gan WJ, et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation[J]. J Allergy Clin Immunol, 2014, 134(2): 440-450.
|
| 34 |
周林福，胡志斌，谢 维，等. Toll样受体4基因多态性和内毒素在哮喘发病中的交互作用[J]. 中华医学杂志，2010, 90(2): 131-133.
|
| 35 |
Sahiner UM, Semic-Jusufagic A, Curtin JA, et al. Polymorphisms of endotoxin pathway and endotoxin exposure: in vitro IgE synthesis and replication in a birth cohort[J]. Allergy, 2014, 69(12): 1648-1658.
|
| 36 |
Sahin F, Yildiz P, Kuskucu A, et al. The effect of CD14 and TLR4 gene polymorphisms on asthma phenotypes in adult Turkish asthma patients: a genetic study[J]. BMC Pulm Med, 2014, 14: 20.
|
| 37 |
Zhang Q, Qian FH, Zhou LF, et al. Polymorphisms in toll-like receptor 4 gene are associated with asthma severity but not susceptibility in a Chinese Han population[J]. J Investig Allergol Clin Immunol, 2011, 21(5): 370-377.
|
| 38 |
Skovbakke SL, Franzyk H. Anti-inflammatory properties of antimicrobial peptides and peptidomimetics: LPS and LTA neutralization[J]. Methods Mol Biol, 2017, 1548: 369-386.
|
| 39 |
Pulido D, Garcia-Mayoral MF, Moussaoui M, et al. Structural basis for endotoxin neutralization by the eosinophil cationic protein[J]. FEBS J, 2016, 283(22): 4176-4191.
|
| 40 |
Menghini R, Campia U, Tesauro M, et al. Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis[J]. PLoS One, 2014, 9(6): e99053.
|
| 41 |
Paramo T, Tomasio SM, Irvine KL, et al. Energetics of endotoxin recognition in the Toll-like receptor 4 innate immune response[J]. Sci Rep, 2015, 5: 17997.
|
| 42 |
Kim Y, Lee H, Heo L, et al. Structure of vaccinia virus A46, an inhibitor of TLR4 signaling pathway, shows the conformation of VIPER motif[J]. Protein Sci, 2014, 23(7): 906-914.
|
| 43 |
Loyau J, Malinge P, Daubeuf B, et al. Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcgamma receptors[J]. MAbs, 2014, 6(6): 1621-1630.
|
| 44 |
Cai B, Wang M, Zhu X, et al. The Fab fragment of a humanized anti-Toll like receptor 4 (TLR4) monoclonal antibody reduces the lipopolysaccharide response via TLR4 in mouse macrophage[J]. Int J Mol Sci, 2015, 16(10): 25502-25515.
|
| 45 |
杨 瑾，唐 奇，熊四平，等. 人源抗TLR4抗体IgG的制备及其中和特性分析[J]. 南京医科大学学报(自然科学版), 2015, 35(6): 777-781, 786.
|
| 46 |
Xiang Y, Eyers F, Herbert C, et al. MicroRNA-487b is a negative regulator of macrophage activation by targeting IL-33 production[J]. J Immunol, 2016, 196(8): 3421-3428.
|
| 47 |
Lochhead RB, Ma Y, Zachary JF, et al. MicroRNA-146a provides feedback regulation of lyme arthritis but not carditis during infection with Borrelia burgdorferi[J]. PLoS Pathog, 2014, 10(6): e1004212.
|
| 48 |
Thounaojam MC, Kundu K, Kaushik DK, et al. MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1[J]. J Virol, 2014, 88(9): 4798-4810.
|
| 49 |
Zhang F, Huang G, Hu B, et al. Anti-HMGB1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell-mediated Th17 polarization[J]. Mediators Inflamm, 2014, 2014: 257930.
|
| 50 |
Zhang F, Huang G, Hu B, et al. Recombinant HMGB1 A box protein inhibits Th17 responses in mice with neutrophilic asthma by suppressing dendritic cell-mediated Th17 polarization[J]. Int Immunopharmacol, 2015, 24(1): 110-118.
|
| 51 |
Zhang Y, Xu T, Wu B, et al. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury[J]. J Cell Mol Med, 2017, 21(4): 746-757.
|
| 52 |
Qin MZ, Gu QH, Tao J, et al. Ketamine effect on HMGB1 and TLR4 expression in rats with acute lung injury[J]. Int J Clin Exp Pathol, 2015, 8(10): 12943-12948.
|
| 53 |
Feng G, Sun B, Li TZ. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-κB pathway[J]. Int Immunopharmacol, 2015, 26(2): 392-400.
|
| 54 |
Wu Z, Tan B, Zhang H, et al. Effects of sodium houttuyfonate on pulmonary inflammation in COPD model rats[J]. Inflammation, 2017, 40(6): 2109-2117.
|
| 55 |
Chen Z, Bai FF, Han L, et al. Targeting neutrophils in severe asthma via Siglec-9[J]. Int Arch Allergy Immunol, 2018, 175(1-2): 5-15.
|